• Apyx Medical reported published clinical data on May 21, 2026 in Aesthetic Surgery Journal Open Forum from a prospective, investigator-initiated study evaluating a combined use of Avéli subcision followed by the company’s Renuvion device for cellulite and skin laxity.
• The results have already been presented in the publication, covering outcomes through 180 days in 22 patients treated in a single session.
• The study showed visible, sustained improvement in cellulite appearance over time, with imaging indicating meaningful reductions in dimpling in some cases.
• Findings also supported improved skin quality consistent with ongoing tissue remodeling, based on laboratory analysis in a subset of patients.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Apyx Medical Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202605210800PRIMZONEFULLFEED9724310) on May 21, 2026, and is solely responsible for the information contained therein.